The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Controlled trial of metronidazole treatment for prevention of crohn's recurrence after ileal resection
Abstract
Background/aims New lesions recur within weeks to months after ileal resection and ileocolonic anastomosis for Crohn's ileitis. A double-blind controlled trial was performed using metronidazole to prevent recurrence after ileal resection.Methods Sixty patients who underwent curative ileal resection and primary anastomosis were included within 1 week after surgery. Thirty patients received metronidazole (20 mg/kg body wt) daily for 3 months, and 30 patients received placebo. Treatment was then discontinued. Nine patients dropped out during treatment, 7 in the metronidazole group and 2 in the placebo arm.Results At 12 weeks, 21 of 28 patients (75%) in the placebo group had recurrent lesions in the neoterminal ileum as compared with 12 of 23 patients (52%) in the metronidazole group (P = 0.09). The incidence of severe endoscopic recurrence was significantly reduced by metronidazole (3 of 23; 13%) as compared with placebo (12 of 28; 43%; P = 0.02). Patients in the metronidazole arm had more frequent side effects. Metronidazole therapy statistically reduced the clinical recurrence rates at 1 year (4% vs. 25%). Reductions at 2 years (26% vs. 43%) and 3 years (30% vs. 50%) were not significant.Conclusions Metronidazole therapy for 3 months decreases the severity of early recurrence of Crohn's disease in the neoterminal ileum after resection and seems to delay symptomatic recurrence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients who have had a resection for CD have a decreased rate of endoscopic and clinical recurrence when metronidazole or ornidazole are used as prophylactic therapies.78”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [78]
In the citing paper
“Antibiotics demonstrate efficacy in particular groups of patients with CD”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [78]
Citations
Cites
Predictability of the postoperative course of Crohn's disease
Rutgeerts, P., Geboes, K., Vantrappen, G., Beyls, J., Kerremans, R., & Hiele, M. I. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90613-6 · Cited by 1,814
Self-citationNatural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery.
Rutgeerts, P., Geboes, K. P., Vantrappen, G. R., Kerremans, R., Coenegrachts, J. L., & Coremans, G. (1984) · Gut · doi:10.1136/gut.25.6.665 · Cited by 785
Self-citationEffect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum
Rutgeerts, P., Peeters, M., Hiele, M. I., Vantrappen, G. R., Pennincx, F., Aerts, R., Kerremans, R., & Goboes, K. (1991) · The Lancet · doi:10.1016/0140-6736(91)90663-a · Cited by 758
Self-citationDouble blind, placebo controlled trial of metronidazole in Crohn's disease.
Sutherland, L. R., Singleton, J., Sessions, J. T., Hanauer, S., Krawitt, E. L., Rankin, G. B., Summers, R. J., Mekhjian, H. S., Greenberger, N. J., & Kelly, M. (1991) · Gut · doi:10.1136/gut.32.9.1071 · Cited by 527
Olaison, G., Smedh, K., & Sjödahl, R. (1992) · Gut · doi:10.1136/gut.33.3.331 · Cited by 497
Healing of perineal Crohn's disease with metronidazole
Bernstein, L. H., Frank, M. S., Brandt, L. J., & Boley, S. J. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90155-9 · Cited by 440
Confidence Intervals for Reporting Results of Clinical Trials
Simon, R. M. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-3-429 · Cited by 410
Ursing, B., Alm, T., Bárány, F., Bergelin, I. S. S., Ganrot-Norlin, K., Hoevels, J., Huitfeldt, B., Järnerot, G., Krause, U., Krook, A. L., et al. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80189-3 · Cited by 351
Controlled trial of bowel rest and nutritional support in the management of Crohn's disease
Greenberg, G. R., Fleming, C. R., Jeejeebhoy, K. N., Rosenberg, I. H., Sales, D., & Tremaine, W. J. (1988) · Gut · doi:10.1136/gut.29.10.1309 · Cited by 296
Sample Size Nomograms For Interpreting Negative Clinical Studies
Young, M., Bresnitz, E. A., & Strom, B. L. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-2-248 · Cited by 251
Research works printed but not linked: 1
- Malchow, 1987, The early signs of Crohn's disease after surgery: a prospective trial, Gastrointest Endosc, 33, 163
Cited by
Sorted by citations
Items 601–700 of 741
Therapiealgorithmen für die Behandlung des Morbus Crohn im klinischen Alltag
Sulz, M. C., Duetschler, J., & Seibold, F. (2020) · Schweizer Gastroenterologie · doi:10.1007/s43472-020-00009-9 · Cited by 1
Probiotics, Prebiotics, and Antibiotics in Medical Management of Inflammatory Bowel Disease
Gionchetti, P., & Rizzello, F. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0998-4_43 · Cited by 1
Surgical Treatment of Inflammatory Bowel Disease
Finlayson, E. V. A., & Michelassi, F. (2008) · Textbook of Gastroenterology · doi:10.1002/9781444303254.ch58 · Cited by 1
Weinstock, J. V. (2004) · Elsevier eBooks · doi:10.1016/b978-044451271-0.50051-x · Cited by 1
Do Antibiotics have a Role in Crohn's Disease?
Vermeire, S., & Rutgeerts, P. (2006) · doi:10.1002/9780470753170.ch16 · Cited by 1
Self-citationIndicaciones de la azatioprina (o 6-mercaptopurina) en la enfermedad inflamatoria intestinal
Cabré, E. (2002) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(02)79028-6 · Cited by 1
Probióticos y enfermedad inflamatoria intestinal
Borruel, N., Casellas, F., & Guarner, F. (2002) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(02)70312-9 · Cited by 1
Bourreille, A. (2005) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(05)80774-2 · Cited by 1
Update gastroenterologie 1997 — Teil I
Fischbach, W., Groß, V., Schölmerich, J., Ell, C., Layer, P., Fleig, W. E., & Zirngibl, H. (1998) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/bf03043280 · Cited by 1
Dubinsky, M. C. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01298.x · Cited by 1
“Studies of metronidazole (20 mgskg) have suggested that it is effective both endoscopically (at 3 months) and clinically (at 12 months) for the prevention of postoperative recurrence”
BackgroundNutrition and Crohn’s disease: a case study in ambiguity
Ooi, C. J., & Podolsky, D. K. (2000) · Nutrition · doi:10.1016/s0899-9007(99)00239-7 · Cited by 1
Medical management of Crohn's disease: current therapy and recent advances
Behm, B. W., & Bickston, S. J. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2.1.109 · Cited by 1
Medical therapy of inflammatory bowel disease
Lichtenstein, G. R. (2004) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2004.05.003 · Cited by 1
VSL#3 in Postoperative Crohn’s Disease
Manship, T. A., & Ford, A. C. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.01.024 · Cited by 1
Role of antibiotics and probiotics in the management of inflammatory bowel disease
Marteau, P. R., & Shanahan, F. (2007) · Springer eBooks · doi:10.1007/0-387-25808-6_28 · Cited by 1
“daily or placebo for 3 months [56].”
BackgroundThe use of probiotics in inflammatory bowel disease
Campieri, M., Gionchetti, P., Rizzello, F., & Venturi, A. (2000) · Springer eBooks · doi:10.1007/978-94-011-4002-7_25 · Cited by 1
Maintenance of remission in Crohn’s disease
Rutgeerts, P. (2000) · Springer eBooks · doi:10.1007/978-94-011-4002-7_14 · Cited by 1
Self-citationJacobstein, D., & Kader, H. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-73481-1_25 · Cited by 1
Genes, bacteria and inflammatory bowel disease
Carter, M. J., & Lobo, A. (2001) · Colorectal Disease · doi:10.1046/j.1463-1318.2001.003s2002.x · Cited by 1
Newton, J. M., Edwards, W. J. S., Thompson, G. S., Gentekaki, E., & Tsaousis, A. D. (2024) · medRxiv · doi:10.1101/2024.07.25.24310942 · Cited by 1
“Antibiotic administration has been an effective treatment for some IBS cases and other GI conditions, while metronidazole, ciprofloxacin and rifaximin have been effective at decreasing the severity of symptoms in many clinical trials [18], [19], [24], [25], [26].”
BackgroundPrévention des récidives de la maladie de Crohn : pourquoi et comment?
Nahon, S., & Poupardin, C. (2006) · Acta Endoscopica · doi:10.1007/bf03018513
“Le mdtronidazole et l'ornidazole sont des antibiotiques imidazolds, qui ont dtd proposals dans la prdvention des rdcidives post-opdratoires [29, 30].”
BackgroundThe Natural History of Crohn Disease in Children
Markowitz, J. F. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5061-0_7
Ramírez, V. H. (2015) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2015.3990/2015
Il trattamento combinato della malattia perianale di Crohn: chirurgia e farmaci biologici
Laureti, S. (2008) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/710
Antibiotics: Which, When, and For How Long?
Kent, A., & Colombel, J. (2006) · doi:10.1002/9780470750827.ch10
Sinha, C. K., & Coran, A. G. (2010) · Springer eBooks · doi:10.1007/978-1-84882-132-3_28
New Insights into Inflammatory Bowel Disease Epidemiology – Are There any Lessons for Treatment?
Bernstein, C. N. (2011) · KARGER eBooks · doi:10.1159/000322433
Holma, R. (2002) · Työväentutkimus Vuosikirja
Medikamentöse Therapie des Morbus Crohn
Adler, G. (1996) · Springer eBooks · doi:10.1007/978-3-642-61023-3_17
Diagnostic and Therapeutic Approaches to Postoperative Recurrence in Crohn's Disease
Assche, G. V., Vermeire, S., & Rutgeerts, P. J. (2010) · doi:10.1002/9781444318418.ch33
Self-citationFeagan, B. G., & McDonald, J. W. (2010) · doi:10.1002/9781444314403.ch11
Weinstock, J. V. (2014) · ASM Press eBooks · doi:10.1128/9781555817879.ch11
Penner, R., & Madsen, K. L. (2006) · Wiley eBooks · doi:10.1002/9780470753170.ch4
Crohn's Disease: From an Anesthetist’s Perspective
Zencirci, B. (2012) · InTech eBooks · doi:10.5772/27126
Interdisziplinäre Leitlinien: Entzündliche Darmerkrankungen — M. Crohn, Colitis ulcerosa
Caspary, W. F. (1997) · Springer eBooks · doi:10.1007/978-3-642-60881-0_18
Geboes, K. J., & Jouret, A. (1999) · Acta Endoscopica · doi:10.1007/bf03019410
“Using a microscopic score composed of the major diagnostic features and criteria indicative o f activity a good correlation between histology and endoscopy was found in different studies evaluating medical treatment prescribed in order to prevent or to treat postoperative recurrent CD [44, 45].”
BackgroundMethodSelf-citationPostoperative Prevention of Relapse in Crohn’s Disease
Keshava, A., & Bartolo, D. C. C. (2006) · Springer eBooks · doi:10.1007/88-470-0434-9_21
Récidive postopératoire de la maladie de Crohn : quelle prise en charge en 2010 ?
Zallot, C., & Peyrin‐Biroulet, L. (2010) · Hépato-Gastro & Oncologie Digestive · doi:10.1684/hpg.2010.0464
Medical therapy of inflammatory bowel diseases: Crohn’s disease
Lakatos, L., & Lakatos, P. L. (2007) · Orvosi Hetilap · doi:10.1556/oh.2007.28062
Prantera, C., & Scribano, M. L. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20650
Bacteria, bugs, and BID rifaximin for Crohnʼs disease
Scherl, E. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20119
Treatment of Crohn's disease: newer therapies
Scribano, M. L., & Prantera, C. (2000) · Techniques in Coloproctology · doi:10.1007/s101510050040
“A recent study on metronidazole in the prevention of recurrence in Crohn’s ileitis after operation showed that the antibiotic, used for a 3month period, decreased the severity of early endoscopic recurrence in the neoterminal ileum, in comparison to placebo, and also seemed to delay the symptomatic recurrence at 1 yea…”
To Yeast or Not to Yeast: A Probiotic Question
Quezada, S. M., & Cross, R. K. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.03.036
Surgery for Small Bowel Crohn’s Disease
Rooney, P., & Eardley, N. J. (2011) · Springer eBooks · doi:10.1007/978-0-85729-889-8_21
Antibiotics, Probiotics, Prebiotics, Fish Oil and Micronutrients (Present)
Steinhart, A. H. (2006) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200610003-00026
When should medical treatment of Crohn’s disease stop?
Hultén, L. (2001) · Colorectal Disease · doi:10.1111/j.1463-1318.2001.00005.x
Chirurgische Therapie des Morbus Crohn
Betzler, M. (1998) · Visceral Medicine · doi:10.1159/000012482
Recurrent Disease After Resection for Crohn's Disease
Cottone, M. (2006) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200610003-00028
Are antibiotics useful in the treatment of IBD?
Alqhatani, S., Sutherland, L. R., & Panaccione, R. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20707
Actualización del tratamiento médico de la enfermedad de Crohn
Chaparro, M., & Gisbert, J. P. (2012) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(12)70300-1
Current and future therapies for inflammatory bowel disease
Zisman, T. L., & Kane, S. V. (2007) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.1.1.89
Hellara, O., Mansour, W. B., Chaabene, N. B., Smaili, R., Melki, W., Loghmari, M. H., Bdioui, F., Safer, L., & Saffar, H. (2013) · Journal Africain d Hépato-Gastroentérologie · doi:10.1007/s12157-013-0475-y
Commensal microbes, immune reactivity and childhood inflammatory bowel disease
Barkman, C. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Surgery and immuno modulation in Crohn's disease
Myrelid, P. (2009) · DiVA (Linkoping University)
Clinical trials: A surgeon's perspective
McLeod, R. S. (1996) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780020106
What is the optimal maintenance treatment for Crohnʼs disease?
Seibold, F. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20672
Ileal Crohn's disease is best treated by surgery C J Windsor
Windsor, A. C. J. (2001)
Treatment of 5-ASA Responders And Nonresponders
Scherl, E. (2007)
Crohn's and Colitis: Treatment of 5-ASA Responders
Scherl, E. (2009)
Direktor, Ä., & Schwab, M. (2009)
Weitzman, G., Feuerstadt, P., & Scherl, E. (2006)
Maladie de Crohn. Récidives post-opératoires. Conduite à tenir
Bélaïche, J., & Louis, E. J. (1999) · Acta Endoscopica · doi:10.1007/bf03019415
Probiotika und Antibiotika bei chronisch entzündlichen Darmerkrankungen (CED)
Hartmann, F. (2001) · Springer eBooks · doi:10.1007/978-3-642-59556-1_10
Biological Approach in the Treatment of Crohn’s Disease
Frulloni, L., Bernardoni, L., Scattolini, C., & Vantini, I. (2007) · Springer eBooks · doi:10.1007/88-470-0434-9_16
Chronisch-entzündliche Darmerkrankungen
Mössner, J., & Siegmund, B. (2014) · Der Internist · doi:10.1007/s00108-013-3439-9 · Cited by 3
Rabizadeh, S., Hyams, J. S., & Dubinsky, M. C. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0774-8.10044-2
Postoperative Therapie und Remissionserhaltung bei Morbus Crohn
Fried, M. (2013)
Aus der Allgemein- und Viszeralchirurgie
Krefeld, K. (2003)
Surgical Management of Intestinal Lesions in Crohn's Disease
Funayama, Y., Takahashi, K. P., Fukushima, K., Ogawa, H., Haneda, S., Watanabe, K., Suzuki, H., & Sasaki, I. (2010) · Nihon Daicho Komonbyo Gakkai Zasshi · doi:10.3862/jcoloproctology.63.875
Clinical Trials: A Surgeonʼs Perspective
McLeod, R. S. (1996) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199603000-00005
childrenoutcome of Crohn's disease in 30
Besnard, M., Jaby, O., & Mougenot, J. F. (2010)
Leiper, K., Registrar, S., & Liverpool, R. (2003)
TEMA 9. ANTIBIÓTICOS, PROBIÓTICOS Y PREBIÓTICOS EN LA ENFERMEDAD INFLAMATORIA INTESTINAL
Aguilar, F. C., Ramos, C. R., & Gallego, M. M. (2008)
Pharmakotherapie chronisch entzündlicher Darmerkrankungen
Nikolaus, S., Schreiber, S., & Fölsch, U. R. (2005) · Der Internist · doi:10.1007/s00108-005-1386-9
Prevention of Short Bowel Syndrome in Crohn’s Disease
Fazio, V. W., & Zutshi, M. (2004) · CRC Press eBooks · doi:10.1201/9780203504581.ch17
Crohn's Disease: Clinical Manifestations and Management
MELMED, G. Y., & Targan, S. R. (2015) · Yamada's Textbook of Gastroenterology · doi:10.1002/9781118512074.ch72
Inflammatory Bowel Disease: Current Pharmacotherapy Issues
Boger, M. S., & Raasch, R. H. (1999) · Journal of Pharmacy Practice · doi:10.1177/089719009901200606
McLeod, R. S. (2003) · Springer eBooks · doi:10.1007/978-1-4020-3477-0_34
Post-operative Prophylaxis in Patients with Crohn’s Disease
Erlich, J. M., & Rubin, D. T. (2017) · Difficult decisions in surgery: an evidence-based approach · doi:10.1007/978-3-319-40223-9_11
Prevention of postsurgical recurrence in Crohn’s disease: is it possible?
Serban, D. E. (2013) · DOAJ (DOAJ: Directory of Open Access Journals)
Postoperative Surveillance and Management of Crohn’s Disease
Barrie, A. M., & Regueiro, M. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-49215-5_43
Postoperative Therapie und Remissionserhaltung bei Morbus Crohn
Maul, J., & Siegmund, B. (2014) · coloproctology · doi:10.1007/s00053-014-0469-2
CLINICAL—ALIMENTARY TRACT Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection
Regueiro, M. D., Schraut, W. H., Baidoo, L., Kip, K. E., Sepulveda, A. R., Pesci, M., Harrison, E. M., & Plevy, S. E. (2009)
Butyrate and the colonic epithelial barrier: prevention of bacterial transcytosis
Lewis, K. J. (2009) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/16948
Omics technologies and the choice of treatment strategy for inflammatory intestinal diseases
Угаров, И. В., Смирнова, О. А., Lychkova, A. E., & Kostyuchenko, L. N. (2018) · Russian Journal of Evidence-Based Gastroenterology · doi:10.17116/dokgastro2018703118
“У пациентов с БК, у которых были резекции, показано снижение скорости повторных случаев, если метронидазол или омидазол использованы в качестве профилактического лечения [163].”
Postoperative Therapie und Remissionserhaltung bei Morbus Crohn
Maul, J., & Siegmund, B. (2013) · Die Gastroenterologie · doi:10.1007/s11377-012-0727-1
Khanna, R., Levesque, B. G., McDonald, J. W., & Feagan, B. G. (2019) · Wiley eBooks · doi:10.1002/9781119211419.ch10
Preventing Postoperative Crohn’s Disease Recurrence
Cohen, E. R., & MELMED, G. Y. (2019) · Springer eBooks · doi:10.1007/978-3-030-16755-4_25
Construction of the Ideal Ileocolic Anastomosis in Crohn’s Disease
Brown, R. F., & Fichera, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-16755-4_22
METRONIDAZOLE TO PREVENT CROHN'S RECURRENCE.
Brett, A. (1995) · Journal watch · doi:10.1056/jw199506270000002
Alexander, F. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-02842-4.50096-6
Optimal strategies to prevent recrudescent Crohn's disease after resection
Queiroz, N. S. F., Yamamoto, T., & Kotze, P. G. (2020) · Seminars in Colon and Rectal Surgery · doi:10.1016/j.scrs.2020.100746
Kim, E. S., & Heo, Y. (2020) · Drugs & Therapy Perspectives · doi:10.1007/s40267-020-00758-2
Ossa, J. C. (2012) · TSpace (University of Toronto)
Postsurgical Treatment in Pediatric Patients With Crohn’s Disease: Physician Practice
Rimon, R. M., Garah, J., Rosen, I., & Shaoul, R. R. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa330
Surgery and stomas in Crohn's disease
Kalman, T. D. (2021) · Linköping University medical dissertations · doi:10.3384/diss.diva-172781
Prevention of Post-operative Recurrence in Crohn's Disease
Jong, K. H. (2008) · Intestinal Research
Enterobacter Ludwigii Protects Experimental Colitis Through CD103+DC and Treg CellsPreprint
Li, Q., Sun, X., Yu, K., Lv, J., Miao, C., Yang, J., Wang, S., Fu, Z., Zhang, H., Zhang, Z., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-69321/v1
La récidive post-opératoire de la maladie de Crohn : état des lieux et perspectives
Valibouze, C., Desreumaux, P., & Zerbib, P. (2021) · Journal de Chirurgie Viscérale · doi:10.1016/j.jchirv.2021.01.012
Metadata
- Authors
- Rutgeerts, P., Hiele, M., Geboes, K., Peeters, M., Penninckx, F., Aerts, R., & Kerremans, R.
- Affiliations
- Universitair Ziekenhuis Leuven (BE)
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 1995-06
- Volume
- 108
- Issue
- 6
- Pages
- 1617-1621
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1980212383
- Cited by
- 743
- References
- 24
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 14 · 2023: 14 · 2022: 6 · 2021: 13 · 2020: 18 · 2019: 17 · 2018: 13 · 2017: 26 · 2016: 27 · 2015: 28 · 2014: 28 · 2013: 25 · 2012: 28
- FWCI
- 10.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Surgery › Diverticular Disease and Complications
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- metronidazole, Crohn's disease, ileal resection, ileocolic anastomosis, postoperative recurrence, recurrence prevention, endoscopic recurrence
- MeSH terms
- Adult, Crohn Disease, Double-Blind Method, Follow-Up Studies, Humans, Ileum, Metronidazole, Middle Aged, Recurrence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
